Eyewire Today

Advertisement

Local ROCK Inhibition Highly Effective in Lowering IOP in Glaucoma Model While Avoiding Hyperemia

From Amakem NV

Amakem NV, a kinase platform company focusing on ophthalmology, presented key preclinical data on its potent, locally active Rho Kinase (ROCK) inhibitor AMA0076 at the 2012 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting being held at Fort Lauderdale. The ARVO meeting is the worlds largest gathering of international eye a...

Login to read story

Tuesday, September 23, 2014

Show last days of articles

Ophthotech Names Michael G. Atieh as Executive Vice Presiden...

From Ophthotech — 9/23/2014

Ophthotech Corp. announced that Michael G. Atieh has been named Executive Vice President, Chief Financial and Business Officer and Treasurer effective...Full story

Crackdown Targets Inversions Designed to Limit U.S. Taxes

From Bloomberg — 9/23/2014

The Treasury Department announced steps that will make it harder for U.S. companies to move their addresses outside the country to reduce taxes, clamp...Full story

How the Brain Processes Color and Motion Provides New Unders...

From Medical News Today — 9/23/2014

Despite the barrage of visual information the brain receives, it retains a remarkable ability to focus on important and relevant items. This fall, for...Full story

New Target Identified for Treatment of Abnormal Blood Vessel...

From Medical News Today — 9/23/2014

Working with mice, a multicenter team of researchers has found a new way to reduce the abnormal blood vessel growth and leakage in the eye that accomp...Full story

Monday, September 22, 2014

Lenstar With T-Cone Attachment Allows Surgeons to Plan Toric...

From Lenstar — 9/22/2014

Surgeons can now completely plan toric surgery using Haag-Streit USAs Lenstar 900 Biometer with T-Cone attachment, according to a company news release...Full story

Bayer Receives Approval for Eylea for the Treatment of Myopi...

From Bayer — 9/22/2014

Bayer HealthCare has received approval from the Ministry of Health, Labor and Welfare (MHLW) in Japan for Eylea (aflibercept solution for injection) f...Full story

Clinical Study Validates Electrical Brain Stimulation Techno...

From EBS Technologies — 9/22/2014

EBS Technologies announced that a clinical study (Brain functional connectivity network breakdown and restoration in blindness) published in the journ...Full story

Vitamin E, Selenium: No Effect on Cataract Risk in Men

From Medscape Ophthalmology — 9/22/2014

Selenium and vitamin E supplementation are unlikely to affect age-related cataract development in older men, according to an article published online ...Full story

Detecting Diabetic Retinopathy Before Vision Fails

From Medical News Today — 9/22/2014

New research in The FASEB Journal suggests that by using molecular imaging probes that target the surface of small blood vessels, diabetic retinopathy...Full story

Friday, September 19, 2014

Valeant Acquisition Provides Pipeline for Expansion of Bausc...

From Bausch + Lomb — 9/19/2014

Bausch + Lomb announced that the agreement between Valeant and Croma, under which Valeant will distribute Croma's ophthalmology and orthopedics produc...Full story

Envision Kicks Off 2014 Conference with Awards Honoring Cont...

From Envision — 9/19/2014

Envision announced that Second Sight Medical Products, a San Fernando Valley, Calif.-based medical device manufacturer, and Janet Sunness, MD, medical...Full story

China Fines Glaxo $489 Million, Ending Bribery Probe

From Bloomberg — 9/19/2014

China fined GlaxoSmithKline Plc (GSK) a record 297 million pounds ($489 million) and imposed a suspended prison sentence on an executive for bribing d...Full story

Optovue Introduces First Software-Assisted OCT Device to US ...

From Optovue — 9/19/2014

Optovue announced that it has launched its newest device, the iScan, in the United States. iScan is designed to elevate the eye exam by leveraging nex...Full story

Thursday, September 18, 2014

New Data for Tecnis Symfony Presbyopia-Correcting Extended R...

From Abbott Medical Optics — 9/18/2014

Abbott Medical Optics announced positive results from studies of the new Tecnis Symfony Extended Range of Vision IOL at the European Society of Catara...Full story

Endpoint Management Technology Safe, Efficacious for Treatme...

From Topcon Medical Systems Inc. — 9/18/2014

Topcon Medical Laser Systems announced publication of a study affirming the clinical safety and efficacy of non-damaging photo-thermal therapy for the...Full story

Leica Microsystems' Ophthalmic Surgical Microscopes with Tru...

From Leica Microsystems — 9/18/2014

Leica Microsystems and TrueVision 3D Surgical have announced global availability of the Leica M844 and Leica M822 ophthalmology microscopes with TrueV...Full story

Topcon Introduces the TRC-NW400 Non-Mydriatic Retinal Camera

From Topcon Medical Systems Inc. — 9/18/2014

Topcon Medical Systems has announcd the release of the fully automatic TRC-NW400 non-mydriatic retinal camera. With the new camera, operators no longe...Full story

NovaBay Pharmaceuticals Creates Optometry Advisory Board

From NovaBay Pharmaceuticals Inc. — 9/18/2014

NovaBay Pharmaceuticals announced that it has created an Optometry Advisory Board to help oversee the development, marketing and medical use of NovaBa...Full story

The Vision Council Names R. Michael Daley as New Chief Execu...

From VisionMonday — 9/18/2014

R. Michael (Mike) Daley has been named as the chief executive officer of The Vision Council, effective Oct. 1, 2014, following the previously announce...Full story

Katalyst Surgical Announces FDA Clearance to Market Oertli C...

From Katalyst Surgical LLC — 9/18/2014

Katalyst Surgical LLC announced that it will be the first distributor in the United States of Oertli's phaco machine, Catarhex3, according to a compan...Full story

Advertisement

Featured Jobs
  • General Ophthalmologist

    , FL (Statewide)

    Established over 60 years ago, one of Floridas busiest and most respected practices is seeking an experience general ophthalmologist. Ideal candidate will have an interest and experience in glaucoma or light plastics as ...